No abstract available
Keywords:
EGFR mutations; Histologic transformation; Resistance mechanisms.
MeSH terms
-
Acrylamides / therapeutic use
-
Aniline Compounds
-
Carcinoma, Neuroendocrine* / drug therapy
-
Carcinoma, Non-Small-Cell Lung* / drug therapy
-
Carcinoma, Non-Small-Cell Lung* / pathology
-
Drug Resistance, Neoplasm
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / pathology
-
Mutation
-
Protein Kinase Inhibitors / pharmacology
-
Protein Kinase Inhibitors / therapeutic use
Substances
-
Acrylamides
-
Aniline Compounds
-
Protein Kinase Inhibitors
-
osimertinib